Novanta Inc. (NOVT) Q4 2025 Earnings Call Transcript

Novanta Inc. (NOVT) Q4 2025 Earnings Call Transcript

Seeking Alpha • 7 hours ago

Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the fourth quarter and full year 2025. Financial Highlights Three Months Ended December 31,     Year Ended December 31,   (In millions, except per share amounts) 2025     2024     2025     2024   GAAP                       Revenue $ 258.3     $ 238.1     $ 980.6     $ 949.2   Operating Inc.

Business Wire • Feb 23, 2026

Is Novanta Stock a Buy or Sell After Its CEO Dumped 6,500 Shares?

CEO Matthijs Glastra sold 6,500 shares for a transaction value of approximately ~$878,458.68 on Feb. 2, 2026. The transaction represented 5.17% of Matthijs Glastra's holdings at the time.

The Motley Fool • Feb 22, 2026

Will Novanta (NOVT) Beat Estimates Again in Its Next Earnings Report?

Novanta (NOVT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research • Feb 20, 2026

American Capital Management Doubles Down on Novanta Stock, According to Latest SEC Filing

Added 163,005 shares; estimated transaction value of $18.56 million based on quarterly average pricing Quarter-end NOVT position value rose by $23.52 million, reflecting both trading activity and price movement Transaction equaled a 0.82% shift in reported AUM Post-trade stake: 381,866 shares valued at $45.44 million NOVT now represents 2% of fund AUM, which places it outside the fund's top five holdings We're bullish on these 10 stocks ›

The Motley Fool • Feb 20, 2026

Novanta Stock Is Roughly Flat This Past Year, So Why Did One Investor Just Bet $45 Million on Shares?

ACK Asset Management acquired 375,000 shares of Novanta in the fourth quarter. The quarter-end position value increased by $44.62 million due entirely to the new share purchase.

The Motley Fool • Feb 14, 2026

Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 24, 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter 2025 results on Tuesday, February 24, 2026. The Company will host a conference call on Tuesday, February 24, 2026, at 8:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via.

Business Wire • Jan 22, 2026

Goldman Sachs Small/Mid Cap Growth Fund Q3 2025 Portfolio Update

The Goldman Sachs Small/Mid Cap Growth Fund-Institutional Shares underperformed its benchmark, the Russell 2500 Growth Index (net), during the quarter. We initiated a position in Planet Fitness, Inc. (1.3%), a franchiser and operator of fitness centers, during the quarter. We exited our position in American fast casual restaurant chain, Shake Shack Inc. (0.0%), during the quarter.

Seeking Alpha • Jan 5, 2026

Novanta to Present at the CJS Securities 26th Annual New Ideas for the New Year Investor Conference on Wednesday, January 14, 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Chuck Ravetto, Chief Operating Officer, will be participating at the CJS Securities 26th Annual New Ideas for the New Year Investor Conference on Wednesday, January 14, 2026, which is being held virtually. About Novanta Novanta is a leading global supplier of core technology solutions that give medical and advanced in.

Business Wire • Dec 18, 2025

Novanta to Present at the J.P. Morgan 44th Annual Healthcare Conference on Wednesday, January 14, 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the J.P. Morgan 44th Annual Healthcare Conference on Wednesday, January 14, 2026, in San Francisco, California. About Novanta Novanta is a leading global supplier of core technology solutions.

Business Wire • Dec 15, 2025